Matson, Inc. (MATX) Market Cap & Valuation Ratios
Matson, Inc. (MATX) has a market cap of $6.8B, a trailing P/E of 15.4 and a price-to-sales ratio of 2.0, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MATXMatson, Inc.Follow MATX — free
—
Price chart with a free account
- Market cap
- 6.8B
- P/E TTM
- 15.4
- Dividend yield
- 0.6%
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Peers
marine shipping · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| MATX | 6.8 | 15.4 | 2.0 | 10.2 | 1.6% | -0.2% | 15% | 15% |
| KEX | 7.0 | 20.5 | 2.3 | 10.5 | 6.8% | +7% | 14% | 8% |
| SBLK | 3.3 | 11.4 | 3.2 | 7.7 | 8.7% | +6% | 28% | 11% |
| DAC | 2.9 | 5.4 | 2.7 | 4.2 | 12.1% | +2% | 48% | 13% |
| SFL | 1.9 | — | 5.7 | 9.8 | 10.3% | -16% | 28% | 6% |
| CMRE | 1.7 | — | 3.3 | 5.2 | — | -4% | 48% | 10% |
| TEN | 1.6 | 5.4 | 3.4 | 5.5 | -14.0% | +23% | 43% | 9% |
| CCEC | 1.2 | 7.0 | 8.4 | 10.9 | -6.8% | +11% | 54% | 5% |
| GNK | 1.1 | 27.9 | 3.1 | 9.7 | -14.0% | +26% | 13% | 4% |
| SB | 0.8 | 27.0 | 4.2 | 9.4 | 7.3% | -10% | 24% | 4% |
| ASC | 0.8 | 7.8 | 2.2 | 5.2 | 2.1% | +14% | 32% | 18% |
| Median of these 10 | 9.6 | 3.2 | 8.5 | 6.8% | +6% | 30% | 9% |
P/E 15.4 vs. a peer median of 9.6; EV/Sales 2.0 vs. 3.2. MATX's own P/E sits at the 98th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesSFL and CMRE have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Matson, Inc. — questions
- What is Matson, Inc.'s market cap?
- $6.8B.
- What is Matson, Inc.'s P/E ratio?
- 15.4 on trailing twelve-month earnings to 2026-06-30.
- What is Matson, Inc.'s price-to-sales ratio?
- 2.0.
Every figure on this page comes from Matson, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.